The Effect of Most-Favored-Nation Pricing on Business Transactions
Recent US efforts to introduce Most Favored Nation (MFN) drug pricing are creating new layers of uncertainty for transactions involving the commercialization of prescription medicines in the US. These policies – designed to align US drug prices with the lowest prices available in comparable countries – have the potential to reshape deal economics, launch strategies, […]
The post Impact of MFN Pricing on Transactions appeared first on Healthcare & Life Sciences Blog.
Read More